The Drugs for Neglected Diseases initiative (DNDi) company source record lists 422 employees. The visible Drugs for Neglected Diseases initiative (DNDi) management graph includes:
Dr Geetanjali Uppal
Director - Saanvi Ethical Research Llp.
1
0
General
(180)
Chirac Bulanga
Director, Drc Regional Office
1
0
Healthcare
(36)
Alexandra Solomos
Senior Clinical Project Manager Chez Drugs for Neglected Diseases Initiative - Dndi
2
0
Finance
(15)
Debora Magalhaes
Mãe Do João - Finance Manager - Fp&a - Planejamento Financeiro - Obz - Controladoria
0
0
Marketing
(13)
Manisha Sharma
Senior Communications Manager, Dndi
3
0
IT
(13)
Teresia Njeri
Senior Data Analyst and Project Manager
0
0
HR
(5)
Joëlle Vanraes
Qd and Clinical Training Compliance Manager
0
0
Legal
(3)
Beatrice Cherotich
Grant Accounting. Project Management. Compliance
0
0
Sales
(3)
Jean Baptiste Gath Botima
Finance Manager , Partners Management Donor Account Chez Drugs for Neglected Diseases Initiative - Dndi
0
0
Related company intelligence for Drugs for Neglected Diseases initiative (DNDi)
2 same-industry peers
10 with employee estimates
10 with websites
10 with social profiles
4 peer evidence types
Peer evidence source coverage
4 source-backed evidence types support this related-company graph.
same-industry peers, employee benchmarks, website records, and social profiles
Same-industry peers
2 / 10
2 of 10 related companies share this company's industry classification.
Employee benchmarks
10 / 10
10 of 10 related companies include employee estimates.
Website records
10 / 10
10 of 10 related companies include official website records.
Social profiles
10 / 10
10 of 10 related companies include company social profile signals.
Peer link quality filter
High-confidence peer link set
10 related companies met the 2-signal peer-link threshold. Eligible peers average 4.0 source-backed signals.
10
eligible
0
filtered
4.0
avg signals
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
employee scale and peer graph evidence
Employee scale
Smaller than most related peers
This company
422 employees
Related peers
709 median peer employees
7 of 10 related employee-estimated peers are higher.
10 related companies with employee estimates
Peer graph evidence
Multi-signal peer benchmark evidence
This company
Benchmark-ready peer graph
Related peers
3 benchmark dimensions
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
industry context, employee benchmarks, website records, social profiles
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
peer graph strength
size benchmark
size position
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 30% of 10 comparable related peers.
Directional peer-position evidence:
Peer-position evidence combines employee scale above 30% of 10 comparable related peers from related-company records.
Employee scale: 30%
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Peer median size
709 employees
Largest peer by size
Gates Foundation
4.07K employees
Drugs for Neglected Diseases initiative (DNDi) size signal
422 employees
Peer size comparison
7 larger · 3 smaller
Peer scale position
Smaller than most related peers
7 of 10 related employee-estimated peers are higher.
Drugs for Neglected Diseases initiative (DNDi) people graph sample
-
Herve Lecuelle
R&D Portfolio and Planning Head at Dndi
Geneva, Switzerland3 email signals: 1 email signal on dndi.org, 2 non-official email signals -
3 email signals across 3 non-official domains -
Delali A.
Global Executive Leader - Board Member & Advisor - Operator - Biopharma & Healthcare Expertise - Passionate @ People Access
Washington, District of Columbia, United States1 email signal across 1 non-official domain
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Contact research
AeroLeads intelligence
Review reachable contact coverage for Drugs for Neglected Diseases initiative (DNDi)
AeroLeads maps 3 visible contact signals for Drugs for Neglected Diseases initiative (DNDi). Coverage is multi-channel contact coverage.